223 related articles for article (PubMed ID: 30418532)
21. Aligning digital CD8
Conde E; Caminoa A; Dominguez C; Calles A; Walter S; Angulo B; Sánchez E; Alonso M; Jimenez L; Madrigal L; Hernando F; Sanz-Ortega J; Jimenez B; Garrido P; Paz-Ares L; de Castro J; Hernandez S; Lopez-Rios F
Histopathology; 2018 Jan; 72(2):270-284. PubMed ID: 28815764
[TBL] [Abstract][Full Text] [Related]
22. [Adenoid cystic carcinoma of the trachea. Case report and review of the literature on malignant tracheal tumors].
Mahnke CG; Werner JA; Lippert BM; Schlüter E; Rudert H
Laryngorhinootologie; 1994 Aug; 73(8):445-8. PubMed ID: 7945665
[TBL] [Abstract][Full Text] [Related]
23. Patterns of PD-L1 expression and CD8 T cell infiltration in gastric adenocarcinomas and associated immune stroma.
Thompson ED; Zahurak M; Murphy A; Cornish T; Cuka N; Abdelfatah E; Yang S; Duncan M; Ahuja N; Taube JM; Anders RA; Kelly RJ
Gut; 2017 May; 66(5):794-801. PubMed ID: 26801886
[TBL] [Abstract][Full Text] [Related]
24. Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples.
Casadevall D; Clavé S; Taus Á; Hardy-Werbin M; Rocha P; Lorenzo M; Menéndez S; Salido M; Albanell J; Pijuan L; Arriola E
Clin Lung Cancer; 2017 Nov; 18(6):682-691.e5. PubMed ID: 28549836
[TBL] [Abstract][Full Text] [Related]
25. A balanced perspective for management of tracheal salivary gland-type carcinomas.
Denlinger CE
J Thorac Cardiovasc Surg; 2010 Aug; 140(2):394. PubMed ID: 20637918
[No Abstract] [Full Text] [Related]
26. XCL1 expression correlates with CD8-positive T cells infiltration and PD-L1 expression in squamous cell carcinoma arising from mature cystic teratoma of the ovary.
Tamura R; Yoshihara K; Nakaoka H; Yachida N; Yamaguchi M; Suda K; Ishiguro T; Nishino K; Ichikawa H; Homma K; Kikuchi A; Ueda Y; Takei Y; Fujiwara H; Motoyama T; Okuda S; Wakai T; Inoue I; Enomoto T
Oncogene; 2020 Apr; 39(17):3541-3554. PubMed ID: 32115573
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of programmed death 1/programmed death ligand 1 pathway in gastric neuroendocrine carcinomas.
Yang MW; Fu XL; Jiang YS; Chen XJ; Tao LY; Yang JY; Huo YM; Liu W; Zhang JF; Liu PF; Liu Q; Hua R; Zhang ZG; Sun YW; Liu DJ
World J Gastroenterol; 2019 Apr; 25(14):1684-1696. PubMed ID: 31011254
[TBL] [Abstract][Full Text] [Related]
28. Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.
Yu D; Cheng J; Xue K; Zhao X; Wen L; Xu C
Pathol Oncol Res; 2019 Oct; 25(4):1437-1443. PubMed ID: 30361911
[TBL] [Abstract][Full Text] [Related]
29. PD-L1 and PD-L2 Expression Levels Are Low in Primary and Secondary Adenoid Cystic Carcinomas of the Orbit: Therapeutic Implications.
Wolkow N; Jakobiec FA; Afrogheh AH; Kidd M; Eagle RC; Pai SI; Faquin WC
Ophthalmic Plast Reconstr Surg; 2020; 36(5):444-450. PubMed ID: 31990894
[TBL] [Abstract][Full Text] [Related]
30. PD-L1 expression predicts longer disease free survival in high risk head and neck cutaneous squamous cell carcinoma.
Roper E; Lum T; Palme CE; Ashford B; Ch'ng S; Ranson M; Boyer M; Clark J; Gupta R
Pathology; 2017 Aug; 49(5):499-505. PubMed ID: 28666643
[TBL] [Abstract][Full Text] [Related]
31. PD-L1 Expression, T-lymphocyte Subpopulations and Langerhans Cells in Cutaneous Squamous Cell Carcinoma and Precursor Lesions.
Stravodimou A; Tzelepi V; Balasis S; Georgiou S; Papadaki H; Mouzaki A; Melachrinou M; Kourea EP
Anticancer Res; 2021 Jul; 41(7):3439-3448. PubMed ID: 34230139
[TBL] [Abstract][Full Text] [Related]
32. The immune microenvironment and expression of PD-L1, PD-1, PRAME and MHC I in salivary duct carcinoma.
Xu B; Jungbluth AA; Frosina D; Alzumaili B; Aleynick N; Slodkowska E; Higgins K; Ho A; Morris L; Ghossein R; Katabi N
Histopathology; 2019 Nov; 75(5):672-682. PubMed ID: 31237963
[TBL] [Abstract][Full Text] [Related]
33. Long-term survival after resection of primary adenoid cystic and squamous cell carcinoma of the trachea and carina.
Gaissert HA; Grillo HC; Shadmehr MB; Wright CD; Gokhale M; Wain JC; Mathisen DJ
Ann Thorac Surg; 2004 Dec; 78(6):1889-96; discussion 1896-7. PubMed ID: 15560996
[TBL] [Abstract][Full Text] [Related]
34. Immune response and evasion mechanisms in lip carcinogenesis: An immunohistochemical study.
Lopes MLDS; Gonzaga AKG; Mosconi C; Palomino GM; Mendonça EF; Batista AC; Silveira ÉJDD
Arch Oral Biol; 2019 Feb; 98():99-107. PubMed ID: 30468994
[TBL] [Abstract][Full Text] [Related]
35. Relationship between the immune microenvironment of different locations in a primary tumour and clinical outcomes of oesophageal squamous cell carcinoma.
Hatogai K; Fujii S; Kitano S; Kojima T; Daiko H; Yoshino T; Ohtsu A; Takiguchi Y; Doi T; Ochiai A
Br J Cancer; 2020 Feb; 122(3):413-420. PubMed ID: 31761900
[TBL] [Abstract][Full Text] [Related]
36. Programmed Death Ligand 1 and Immune Cell Infiltrates in Solitary Fibrous Tumors of the Pleura.
Tapias LF; Mino-Kenudson M; Choy E; Kem M; Muniappan A; Gaissert HA; Wright CD; Ott HC; Mathisen DJ; Lanuti M
Ann Thorac Surg; 2021 Dec; 112(6):1862-1869. PubMed ID: 33347847
[TBL] [Abstract][Full Text] [Related]
37. The Immunological Impact of Chemotherapy on the Tumor Microenvironment of Oral Squamous Cell Carcinoma.
Takakura H; Domae S; Ono T; Sasaki A
Acta Med Okayama; 2017 Jun; 71(3):219-226. PubMed ID: 28655941
[TBL] [Abstract][Full Text] [Related]
38. Elevated frequencies of CD8 T cells expressing PD-1, CTLA-4 and Tim-3 within tumour from perineural squamous cell carcinoma patients.
Linedale R; Schmidt C; King BT; Ganko AG; Simpson F; Panizza BJ; Leggatt GR
PLoS One; 2017; 12(4):e0175755. PubMed ID: 28423034
[TBL] [Abstract][Full Text] [Related]
39. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes.
Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G
Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907
[TBL] [Abstract][Full Text] [Related]
40. Programmed death-1 ligands 1 and 2 expression in cutaneous squamous cell carcinoma and their relationship with tumour- infiltrating dendritic cells.
Jiao Q; Liu C; Li W; Li W; Fang F; Qian Q; Zhang X
Clin Exp Immunol; 2017 Jun; 188(3):420-429. PubMed ID: 28052400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
